- Home
- IPHA vs MRAM Comparison
IPHA vs MRAM Comparison
Compare IPHA & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- MRAM
- Stock Information
- Founded
- IPHA 1999
- MRAM 2008
- Country
- IPHA France
- MRAM United States
- Employees
- IPHA N/A
- MRAM N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- MRAM Semiconductors
- Sector
- IPHA Health Care
- MRAM Technology
- Exchange
- IPHA Nasdaq
- MRAM Nasdaq
- Market Cap
- IPHA 150.9M
- MRAM 134.5M
- IPO Year
- IPHA 2019
- MRAM 2016
- Fundamental
- Price
- IPHA $1.95
- MRAM $5.80
- Analyst Decision
- IPHA Strong Buy
- MRAM Strong Buy
- Analyst Count
- IPHA 1
- MRAM 2
- Target Price
- IPHA $11.50
- MRAM $9.00
- AVG Volume (30 Days)
- IPHA 50.9K
- MRAM 93.4K
- Earning Date
- IPHA 03-20-2025
- MRAM 02-26-2025
- Dividend Yield
- IPHA N/A
- MRAM N/A
- EPS Growth
- IPHA N/A
- MRAM N/A
- EPS
- IPHA N/A
- MRAM 0.07
- Revenue
- IPHA $36,202,722.00
- MRAM $53,865,000.00
- Revenue This Year
- IPHA N/A
- MRAM N/A
- Revenue Next Year
- IPHA $101.65
- MRAM $7.15
- P/E Ratio
- IPHA N/A
- MRAM $80.91
- Revenue Growth
- IPHA N/A
- MRAM N/A
- 52 Week Low
- IPHA $1.29
- MRAM $4.89
- 52 Week High
- IPHA $3.51
- MRAM $9.39
- Technical
- Relative Strength Index (RSI)
- IPHA 56.50
- MRAM 35.09
- Support Level
- IPHA $1.72
- MRAM $6.11
- Resistance Level
- IPHA $1.92
- MRAM $6.30
- Average True Range (ATR)
- IPHA 0.11
- MRAM 0.23
- MACD
- IPHA 0.02
- MRAM -0.07
- Stochastic Oscillator
- IPHA 89.74
- MRAM 3.48
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).